Journal of Vaccines & Vaccination

6^th Euro Global Summit and Expo on Vaccines & Vaccination

August 17-19, 2015 Birmingham, UK

Scientific Tracks Abstracts

• Deep sequencing of the yellow fever vaccine strain 17D reveals low diversity compared to wild-type parent Asibi virus and population stability for primary and secondary seed lots of 17D vaccine

  Alan D T Barrett

  PDF HTML

• Distinct priming effect of live attenuated versus inactivated influenza vaccines in repeated influenza vaccination

  Xiao-Song He

  PDF HTML

• Designing tumor immunotherapy amidst tumor heterogeneity

  Periasamy Selvaraj

  PDF HTML

• Immunogenicity of sequences around HIV-1 protease cleavage sites: Potential targets and population coverage analysis for a HIV vaccine targeting protease cleavage sites

  Ma Luo1,2, Rupert Capina1, Christina Daniuk1, Jeff Tuff1, Harold Peters1, Makubo Kimani3, Charles Wachihi3, Joshua Kimani3, Terry Blake Ball1,2 and Francis A Plummer1,2

  PDF HTML

• Assessment of hepatitis B vaccination coverage in a population of workers

  Frederic J Deschamps

  PDF HTML

• Streptococcus pyogenes candidate vaccine

  Luiza Guilherme

  PDF HTML

• Safety, tolerability and side effects of human papillomavirus vaccines: A systematic quantitative review

  Ana Katherine Gonçalves1, Cobucci RN2, Rodrigues HM2, de Melo AG2 and Giraldo PC3

  PDF HTML

• Polio returns to Middle East, situation analysis, strategies and way forward

  Randa Hamadeh

  PDF HTML

• Vaginal vaccination with DNA loaded nano-particles

  Gulay Buyukkoroglu

  PDF HTML

• Dengue vaccine: Current status and future strategies

  Abubakar Yaro

  PDF HTML

• A potent candidate black water fever malaria vaccine in the offing, Ugandan case

  Akusa Darlington

  PDF HTML

• Highlighting delays in childhood immunization in low-income countries during conflict: Example from a study in Sierra Leone, West Africa

  Charles Senessie, George N Gage and Erik von Elm

  PDF HTML

• Challenges and successes measuring T cell immunity to vaccines

  Magdalena Tary-Lehmann

  PDF HTML

• A non-replicating Ad5 vaccine for treatment of HSV-2

  Wendy Peters

  PDF HTML

• Developing biophysical methods for optimization of vaccine process and drug product development

  Henryk Mach

  PDF HTML

• Improving uptake of vaccines for pregnant women

  Helen Marshall

  PDF HTML

• Effective vaccine design: Back to the drawing board?

  Geert Vanden Bossche

  PDF HTML

• Brazilian public HPV vaccination program: First two years of experience

  Leandro Santos de Araujo Resende

  PDF HTML

• Systemic vaccination with a tuberculosis subunit vaccine leads to a better containment of the bacterial load in lung of mice treated with retinoic acid

  Silvia Vendetti1, Antonella Riccomi, Valentina Gesa, Elisa Cirelli, Else Marie Agger, Giovanni Piccaro and Carla Palma

  PDF HTML

• â??BUL BIO-NCIPDâ? company with traditions in vaccine production and with a look ahead to future

  Daniela Pencheva

  PDF HTML

• Immunization in Myanmar

  Khin Nyo Thein and Aung C M

  PDF HTML

• Correlation between predicted immune epitopes and protein disorder: An immunoinformatic approach to find vaccine and diagnostic candidates

  Daniela de Melo Resende, Alexandre B Reis and Jeronimo C Ruiz

  PDF HTML

• Ethical challenges with conducting vaccine trials in Africa

  Olubukola T. Idoko

  PDF HTML

• Role of immunization in prevention of nosocomial infections

  Zarema Obradovic

  PDF HTML

• Recent advances in comparative pathology for rift valley fever virus vaccinology

  Ivan Galindo Cardiel I1, Busquets N2, Abad F X2, Solanes D2, Domingo M3 and Brun A4

  PDF HTML

• Immunological effects of HIV-1 p24 fusion to murine HSP70 - cellular response-eliciting strategy

  Raska M, Krupka M and Zachova K

  PDF HTML

• Reactogenicity evaluated via magnetic resonance imaging and pathological examination in pigs

  Maren Bernau1, Prisca Valerie Kremer1,2, Daniela Emrich1, Lena Sophie Kreuzer1, Elke Pappenberger1, Klaus CuÃ?ler4, Andreas Hoffmann3, Miriam Leipig1, Walter Hermanns1 and Armin Manfred Scholz1

  PDF HTML

• Characterization and optimization of a novel vaccine for protection against Lyme borreliosis

  Urban Lundberg

  PDF HTML

• A serological study in response to people at occupational risk of rabies virus exposure in Nepal

  Ganesh Raj Pant, Bol Raj Acharya, Arjun Raj Pant, Manish Man Shrestha, Vivek Pant, Nayana Pant and Dwij Raj Bhatta

  PDF HTML

• Analysis of pancreatic cancer-infiltrating T-lymphocytes reveals that ENO-specific Tregs inhibit the effector T-cells

  Amedeo Amedei

  PDF HTML

• Development of an anti-idiotypic Mab as cancer vaccine: From discovery to approval

  kathya Rashida de la Luz Hernandez1, Julio Santo-Tomás1, Yoan Machado1, Yadira Aguilar1, Svieta Víctores1, Yadira Prieto1, Orlando Morales1, Amparo Macías1, María C Barroso1, Tania Crombet1, Eduardo Ojito1, Yudisleydis Fortunato1, Yanitzia Crespo1, Dasha Fuentes2, Danais Vidal1, Yamilet

  PDF HTML

• Effect of Vaccination to Control Japanese Encephalitis in Nepal: A review

  Ganesh Raj Pant

  PDF HTML

• Outer membrane vesicles as an attractive candidate for pertussis vaccine

  Daniela F. Hozbor, Bottero D, Gaillard E, Rumbo M, Bartel E, Moreno G, Zurita E, Sabater D, Bravo S, Errea A, Flores D, Castuma C and Carriquiriborde F

  PDF HTML

• Prevention of ETEC and STEC infections using recombinant Lactococcus lactis expressing surface nanobodies against F4 and F18 fimbriae

  Okello E1,2,3, Moonens K1,2, De Kerpel M1,2, Erume J3 and De Greve H1,2

  PDF HTML

• Design, Optimization and Efficacy of Viral Vector Vaccine strategies against HIV

  Takis Athanasopoulas

  PDF HTML